Development and applications of the SWAN rating scale for assessment of attention deficit hyperactivity disorder: a literature review.

Braz J Med Biol Res

Departamento de Neurologia, Faculdade de Ciências Médicas, UNICAMP, Campinas, SP, Brasil.

Published: November 2015

AI Article Synopsis

Article Abstract

This study reviewed the use of the Strengths and Weaknesses of Attention-Deficit/Hyperactivity-symptoms and Normal-behaviors (SWAN) rating scale in diagnostic and evolutive approaches to attention deficit hyperactivity disorder (ADHD) and in correlational studies of the disorder. A review of articles published in indexed journals from electronic databases was conducted and 61 articles on the SWAN scale were analyzed. From these, 27 were selected to a) examine use of SWAN in research on attention disorders and b) verify evidence of its usefulness in the areas of genetics, neuropsychology, diagnostics, psychiatric comorbidities, neuroimaging, pharmacotherapy, and to examine its statistical reliability and validity in studies of diverse populations. This review of articles indicated a growing use of the SWAN scale for diagnostic purposes, for therapy, and in research on areas other than ADHD, especially when compared with other reliable scales. Use of the scale in ADHD diagnosis requires further statistical testing to define its psychometric properties.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671522PMC
http://dx.doi.org/10.1590/1414-431X20154528DOI Listing

Publication Analysis

Top Keywords

swan rating
8
rating scale
8
attention deficit
8
deficit hyperactivity
8
hyperactivity disorder
8
scale diagnostic
8
review articles
8
swan scale
8
swan
5
scale
5

Similar Publications

Background: The Montreal Cognitive assessment (MoCA) is a well-validated global cognitive screening instrument. Its validity in progressive supranuclear palsy (PSP) has not been assessed.

Objectives: To evaluate the MoCA as an outcome measure in PSP clinical trials.

View Article and Find Full Text PDF

Patient- and Caregiver-Reported Impact of Symptoms in Alzheimer Disease, Mild Cognitive Impairment, and Dementia.

Neurol Clin Pract

February 2025

University of Rochester School of Medicine and Dentistry (JS, AV); Center for Health and Technology (CHeT) (JS, JW, AV, SJR, CE, AA, CZ, CRH), University of Rochester; University of Utah Spencer Fox Eccles School of Medicine (SJR); Des Moines University College of Osteopathic Medicine (AA); Department of Biostatistics and Neurology (ND), University of Rochester; Alzheimer's Disease Care, Research and Education Program (AD-CARE) (AM, SS-S, EJS), University of Rochester; and Department of Neurology (CRH), University of Rochester.

Background And Objectives: In preparation for future clinical trials involving individuals with Alzheimer disease (AD), mild cognitive impairment (MCI), and dementia, it is important to ascertain the widespread impact of symptoms from the direct perspectives of patients and caregivers. In this study, we performed cross-sectional surveys using large-scale patient and caregiver data to identify the prevalence and average impact of symptoms and symptomatic themes experienced by adults with AD, MCI, and dementia. Subsequent analyses were used to determine which demographic and disease-specific factors are associated with more severe disease.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the effectiveness of Maya, a mobile app providing cognitive behavioral therapy (CBT) for anxiety in young adults aged 18 to 25, addressing the common issue of anxiety disorders among this demographic.
  • Participants engaged in a 6-week program and were divided into three groups, each receiving different text message incentives to encourage involvement, while their anxiety levels were measured using the Hamilton Anxiety Rating Scale.
  • Results showed a significant reduction in anxiety symptoms after the intervention, with participants maintaining improvement even 12 weeks post-treatment, highlighting the potential of digital mental health tools for this age group.
View Article and Find Full Text PDF

The Role of Blood Pressure Control in Prevention of Hematoma After Blepharoplasty.

Aesthetic Plast Surg

July 2024

Department of Plastic and Reconstructive Surgery, Emory University, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.

Introduction: Hematoma formation after blepharoplasty is serious and potentially vision-threatening, with hypertension being the primary risk factor. The aim of this paper is to assess perioperative blood pressure trends and rates of complication in patients undergoing a strict blood pressure protocol designed to keep perioperative systolic blood pressure below 120 mmHg.

Methods: A retrospective chart review was performed of 32 patients undergoing face lift with conomitant blepharoplasty from January 2015 to July 2018.

View Article and Find Full Text PDF

Purpose: Nutrition is essential within cancer care, yet patient and carer access to nutrition care and information is variable. This study aimed to (1) investigate patient and carer access and perceptions, and health professional views and practices, relating to cancer nutrition information and care; and (2) co-design interactive resources to support optimal nutrition care.

Methods: Patients and carers completed a survey regarding access to nutrition care and information.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!